Report #2877715

Received Dec 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: CA
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	4	UNK	—
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	UNK	—

Symptoms (1)

Extra dose administered

Symptom narrative

Patient received 4 doses of Shingrix; This non-serious case was reported by a nurse via sales rep and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (2 doses taken on an unknown date). On an unknown date, the patient received the 4th dose of Shingrix and the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced extra dose administered (Verbatim: Patient received 4 doses of Shingrix). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date 09-DEC-2025 The batch number was not provided and a request for this information had been made.